Corvas Licenses Incyte s LifeSeq Gold Database | GenomeWeb

NEW YORK, Aug 1 –Corvas International has signed a multi-year subscription to Incyte’s LifeSeq Gold database, the companies said Wednesday.

Corvas said it would use the database for its cancer research activities. The San Diego-based company is currently researching serine proteases to determine their potential as solid tumor drug targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.